STOCK TITAN

Ribbon Acquisition (RIBB) 10-K Filings

RIBB NASDAQ

Here are the 10-K annual reports from Ribbon Acquisition Corp (RIBB) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow RIBB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RIBB filings page.

Rhea-AI Summary

Ribbon Acquisition Corporation filed an amendment to its annual report for the year ended December 31, 2025. The amendment is narrow in scope and is being made solely to add the company’s Clawback Policy as Exhibit 97.1, without changing any other disclosures in the original filing.

The company’s securities, including its units, Class A ordinary shares, and rights, remain listed on The Nasdaq Stock Market. As of March 31, 2026, there were 4,793,446 ordinary shares outstanding.

Rhea-AI Summary

Ribbon Acquisition Corporation, a Cayman Islands-based blank check company, files its annual report describing progress toward completing its initial business combination.

The company completed an IPO of 5,000,000 units at $10.00 each and a private placement of 220,000 units at $10.00, placing $50,000,000 of net proceeds into a U.S. trust account for the benefit of public shareholders. On June 30, 2025, Ribbon entered into a Business Combination Agreement with DRC Medicine Inc., DRC Medicine Ltd. and DRC Merger Inc. and is now focused on closing this transaction rather than seeking other targets.

As of March 31, 2026, the company had 4,793,446 ordinary shares outstanding and remained a pre-revenue SPAC relying on offering proceeds and sponsor loans to fund operating costs. Shareholders are granted redemption rights in connection with the business combination or a potential liquidation if no deal is completed within the approved extension period.